S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ORIC Oric Pharmaceuticals Inc

8.52

0.09 (1.07%)

Dec 13 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals Inc News

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Monday 25 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Monday 4 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (1 month ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 9 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 4 October 2024 (2 months ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Friday 6 September 2024 (3 months ago) • GlobeNewswire Inc.

More Oric Pharmaceuticals Inc News Articles

Worldwide NFT (PK)

Tonix Pharmaceuticals

TheGlobe com (PK)

Eyecity Com (PK)

GBT Technologies (PK)

Net Savings Link (PK)

Code Green Apparel (PK)

Liquidmetal Technologies (QB)

Elite Pharmaceuticals (QB)

NioCorp Developments

FuelCell Energy

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions